Stocks and Investing Stocks and Investing
Thu, March 17, 2022

Andrew Berens Downgraded (BGNE) to Hold and Decreased Target to $177 on, Mar 17th, 2022


Published on 2024-10-27 20:07:07 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Downgraded "BeiGene, Ltd." (BGNE) to Hold and Decreased Target from $300 to $177 on, Mar 17th, 2022.

Andrew has made no other calls on BGNE in the last 4 months.



There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $330 on, Monday, February 28th, 2022
Contributing Sources